A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma
| Autor: | Halford, S., Yip, D., Karapetis, C.S., Strickland, A.H., Steger, A., Khawaja, H.T., Harper, P.G. * |
|---|---|
| Zdroj: | In Annals of Oncology October 2001 12(10):1399-1402 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|